Bovine milk oligosaccharides

US10238674B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10238674-B2
Application numberUS-201715655396-A
CountryUS
Kind codeB2
Filing dateJul 20, 2017
Priority dateJul 12, 2010
Publication dateMar 26, 2019
Grant dateMar 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising galacto-oligosaccharides (GOS) and/or fructooligosaccharides (FOS) and/or lactulose and/or lactitol and/or xylooligosaccharides and at least one oligosaccharide from bovine milk or milk product and an inoculum of Bifidobacterium longum subsp. infantis or B. breve , wherein the oligosaccharide is selected from the group consisting of: an oligosaccharide consisting of 3 Hexose (Hex) moieties, 4 N acetyl hexosamine (HexNAc) moieties and 1 fucose (Fuc) moiety; an oligosaccharide consisting of 4 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 5 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 4 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 6 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties and 6 HexNAc moieties, an oligosaccharide consisting of 4 Hex moieties and 3 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 6 Hex moieties and 2 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 5 HexNAc moieties; an oligosaccharide consisting of 5 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 5 HexNAc moieties; and a mixture thereof. 2. The composition of claim 1 comprising at least two oligosaccharides, wherein the at least two oligosaccharide are selected from the group consisting of: an oligosaccharide consisting of 3 Hexose (Hex) moieties, 4 N acetyl hexosamine (HexNAc) moieties and 1 fucose (Fuc) moiety; an oligosaccharide consisting of 4 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 5 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 4 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 6 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties and 6 HexNAc moieties, an oligosaccharide consisting of 4 Hex moieties and 3 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 6 Hex moieties and 2 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 5 HexNAc moieties; an oligosaccharide consisting of 5 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 5 HexNAc moieties. 3. The composition of claim 2 , further comprising a bovine milk protein, a soy protein, betalactoglobulin, whey, soybean oil or starch. 4. The composition of claim 2 , further comprising a non-milk lipid. 5. The composition of claim 1 , further comprising a bovine milk protein, a soy protein, betalactoglobulin, whey, soybean oil or starch. 6. The composition of claim 1 , further comprising a non-milk lipid. 7. The composition of claim 6 , wherein the composition is a liquid and the content of the at least one oligosaccharide in the composition is from 0.001-100 g/L. 8. The composition of claim 1 , wherein the composition is a solid. 9. A method of obtaining one or more of the oligosaccharides recited in claim 1 , comprising purifying the at least one oligosaccharide from bovine milk and further comprising mixing the oligosaccharide with GOS and/or FOS and/or lactulose and/or lactitol and/or xylooligosaccharides.

Assignees

Inventors

Classifications

  • Bacteria or derivatives thereof, e.g. probiotics · CPC title

  • Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00 · CPC title

  • General processes for their isolation or fractionation, e.g. purification or extraction from biomass · CPC title

  • Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06) · CPC title

  • A61K31/702Primary

    Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10238674B2 cover?
Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification A61K31/702. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).